This website uses cookies to improve your experience. You can accept or reject analytics cookies
Plano Brasileiro de Preparação para Enfrentamento de uma Pandemia de Influenza
Pandemic Preparedness and ResponseNational Control Plan2010
BrazilSpanishPDF
National
AI-Generated Document Summary
Objectives
Brazil’s influenza pandemic contingency framework provides flexible, integrated guidance for preparedness, response and recovery, supporting the organisation of the Unified Health System and state and municipal emergency management.Its overarching purpose is to protect population health, reduce pandemic morbidity and mortality, delay the introduction and spread of a pandemic strain, preserve essential services and limit wider social and economic disruption.
Strengthen health-system organisation, infrastructure and preparedness across national, state and municipal levels, alongside relevant non-health sectors and the population.
Detect, notify, investigate and respond rapidly to influenza threats through integrated epidemiological, laboratory, sanitary and health-care surveillance.
Contain early transmission through prompt case identification, treatment, isolation and contact follow-up before sustained community transmission occurs.
Mitigate later transmission through epidemiological monitoring, prioritised care for severe or potentially complicated cases, strengthened clinical networks and continuity of essential health services.
Ensure equitable access to vaccines, immunobiological products, antivirals and strategic reserves, while identifying priority groups for prophylaxis, treatment and vaccination.
Develop and implement pandemic influenza immunisation activities, including technical vaccination standards, cold-chain arrangements, adverse-event surveillance and public education.
Protect health-service users and workers through infection prevention and control, appropriate personal protective equipment and guidance for service organisation.
Inform the public and health professionals through risk communication, educational materials and coordinated action to address rumours and misinformation.
Protect travellers, crews, workers and the public at ports, airports and land borders while maintaining the movement of passengers, cargo, post and essential supplies as far as possible.
Protect animal and public health, including through animal influenza surveillance and control, to reduce pandemic health, social and economic consequences.
Support continuity of trade, agro-industry and economic activity by monitoring restrictions, addressing trade barriers and supporting affected productive sectors.
Implementation
Implementation is coordinated nationally by the Ministry of Health and the Interministerial Executive Group, which was established in 2005 to take decisions on national pandemic influenza preparedness.The plan uses a concise, adaptable model: general cross-sector guidance is organised by World Health Organization pandemic periods and phases, with operational measures and procedures set out in area-specific annexes.
Coordinate federal action through the Interministerial Executive Group, involving health, civil protection, finance, planning, agriculture, foreign affairs, justice, defence, education, transport and other represented public bodies.
Apply a command-and-control structure with defined commitments, organisational arrangements, service responsibilities and decision-making mechanisms for containment and mitigation.
Support states and municipalities to update and implement local plans, investigate outbreaks, reorganise care networks and coordinate action across primary, secondary and tertiary services.
Coordinate preparedness and response through the Health Surveillance Secretariat, including influenza policy, surveillance protocols, early emergency detection, assessment of viral spread and inter-state coordination.
Use the Centre for Strategic Information and Response in Health Surveillance to manage strategic information, coordinate the response network and Permanent Emergency Committee, and support field epidemiological investigations.
Maintain surveillance and laboratory capacity by standardising specimen collection and transport, coordinating public-health laboratory diagnosis, maintaining supplies, monitoring viral circulation and detecting mutations or antiviral resistance.
Deliver immunisation through the General Coordination of the National Immunisation Programme, which oversees technical standards, procurement, storage, distribution, cold-chain management, information systems and support to subnational authorities.
Coordinate pharmacovigilance with the National Health Surveillance Agency, including protocols for adverse events following vaccination, safety-signal detection, regulatory inspections and safety communications on vaccines and oseltamivir.
Strengthen health-care delivery through the Health Care Secretariat by expanding beds, equipping outpatient and hospital services, establishing clinical algorithms and referral flows, and identifying alternatives when existing capacity is exhausted.
Train health workers through coordination of workforce planning, education and professional development, with support for states, municipalities, educational institutions, professional bodies and civil-society partners.
Implement coordinated risk communication through the Ministry of Health Communication Advisory, including public information materials, multilingual communication at points of entry, media partnerships, social-network monitoring and alignment with state communications.
Apply sanitary surveillance at ports, airports and borders through traveller controls, inspections when indicated, cleaning and waste-management measures, case-based epidemiological actions and regularly updated local contingency plans.
Integrate animal-health action through agricultural health authorities, the Unified System for Agricultural Health Attention and international cooperation, including laboratory analysis, control of animal and product movements, information-sharing and personnel training.
Mobilise transport, defence and trade institutions to sustain logistics, emergency transport, secure information flows, route diversions during restrictions, military support and mitigation of export and market-access impacts.
Monitor implementation through monthly Interministerial Executive Group reports, surveillance of pandemic severity and spread, vaccination coverage and adverse events, health-service performance, pharmacovigilance reporting and evaluation during post-peak and post-pandemic recovery.
Monitoring & Evaluation
Monitoring and evaluation centre on integrated epidemiological, laboratory, clinical, immunisation, pharmacovigilance and operational surveillance, coordinated nationally by the Ministry of Health and relevant sectoral bodies. The framework uses World Health Organization pandemic phases, transmission trends, severity assessments and scenario modelling to guide preparedness and response decisions.
Monitor implementation of preventive measures and submit monthly reports to the heads of bodies represented in the Interministerial Executive Group.
Track pandemic risk through notification, investigation and surveillance of new influenza subtypes, infections among travellers arriving from affected areas, severe cases, unusual clusters, respiratory disease admissions, mortality patterns and animal-origin transmission risks.
Assess severity using case-fatality rates, unusual severe disease, unexpected mortality and complications, and use dynamic models to estimate peak demand and duration under low- and high-transmissibility scenarios.
Maintain and update the Information Systems for Notifiable Diseases and the Influenza Epidemiological Surveillance Information System to inform risk assessment and decision-making.
Monitor geographical spread, intensity, impact and disease trends through qualitative indicators, epidemiological trend analysis, case monitoring and laboratory investigation.
Evaluate response effectiveness during post-peak and post-pandemic periods, revise plans, support recovery and maintain surveillance for potential subsequent waves.
Coordinate strategic information through the Centre for Strategic Information and Response in Health Surveillance, including event verification, information consolidation, emergency assessment, field investigations and notification of relevant international events to the World Health Organisation and partners.
Monitor vaccination coverage daily by priority group, municipality and Federative Unit; analyse doses distributed and administered; investigate serious adverse events; and use SI-EAPV and FormeSus systems to collect and report adverse-event information.
Develop vaccination impact-assessment tools, conduct scientific studies and prepare final reports on the pandemic influenza vaccination strategy.
Conduct post-marketing and post-use pharmacovigilance for antivirals and vaccines, identify safety signals, assess periodic reports from registration holders, inspect manufacturer systems and publish safety alerts.
Monitor health-service performance, social-media misinformation, sanitary risks and control measures at ports, airports and borders, including traveller controls and inspections where indicated.
Monitor animal-health actions and epidemiological information, transport-sector compliance with alert-level procedures, aviation operators’ compliance, port capacity and the effects of influenza-related trade restrictions.
Use situation rooms, interconnected data networks and secure standardised information flows to support interministerial monitoring, instructions and decision-making.
A detailed consolidated indicator framework, uniform performance targets, common evaluation methodology and overarching reporting timetable are not specified in the supplied text.
Costing & Financing
Financing provisions emphasise mobilising and tracking resources needed for preparedness and response, optimising existing resources through timely planning, and securing essential supplies, logistics and operational capacity.
Assign the Interministerial Executive Group responsibility for following budgetary and financial resources required to implement plan actions.
Support procurement, storage and distribution arrangements for antivirals, vaccines and other immunobiological products, diagnostic tests, personal protective equipment and related supplies, including a strategic reserve of antivirals and immunobiological products.
Finance construction and equipment for pandemic influenza vaccine production at the Butantan Institute through Ministry of Health resources, without specifying an amount or financing period.
Mobilise logistics, transport, personnel, data infrastructure, military pharmaceutical production and other material support through defence-sector coordination.
Seek credit from the National Bank for Economic and Social Development and other development agencies for industrial working capital and recovery in epidemic-affected areas.
Refer to national guidance on financing health-surveillance actions by the Union, states, Federal District and municipalities, without identifying a plan-specific allocation.
No quantified overall budget, costed activity plan, currency allocation, financing gap, committed funding total or economic assumption is specified in the supplied text.